tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Arcutis Biotherapeutics Inc

ARQT
Add to Watchlist
25.960USD
+0.580+2.29%
Close 09-21 16:00（ET）
3.26BMarket Cap
LossP/E TTM

Arcutis Biotherapeutics Inc

25.960
+0.580+2.29%
Overview
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

Overview

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

ARQT Financials

See Arcutis Biotherapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
3.26B
Dividend TTM
0.00
P/E TTM
-1.69K
EPS TTM
-0.02
Revenue
376.07M
Net Profit
-140.04M
ROE
-1.43%
ROA
-0.59%

Arcutis Biotherapeutics Inc Earnings Date

Latest Release
Aug 5, 2026
EPS / Forecast
0.11/0.04
Revenue / Forecast
129.86M/118.85M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
191.93%0.11
56.09%-0.09
257.08%0.14
117.37%0.06
70.48%-0.13
37.60%-0.20
87.91%-0.09
53.92%-0.33
63.33%-0.42
75.67%-0.32
39.48%-0.71
---0.73
---1.16
---1.31
---1.18
---4.52
----
----
----
----
Revenue
59.33%129.86M
60.07%105.40M
81.48%129.50M
121.69%99.22M
164.13%81.50M
32.84%65.85M
427.58%71.36M
17.44%44.76M
494.57%30.86M
1682.42%49.57M
356.81%13.53M
5156.41%38.11M
--5.19M
--2.78M
--2.96M
--725.00K
----
----
----
----
Net Profit
194.48%15.01M
54.93%-11.29M
261.24%17.39M
117.84%7.41M
69.64%-15.89M
29.17%-25.06M
83.72%-10.79M
7.21%-41.54M
26.28%-52.33M
55.83%-35.38M
7.96%-66.28M
58.44%-44.77M
-5.32%-70.99M
-24.53%-80.10M
-0.97%-72.02M
-89.03%-107.71M
-60.46%-67.41M
-78.47%-64.32M
-109.48%-71.33M
-49.15%-56.98M
Net Margin
159.30%11.56%
71.84%-10.72%
188.85%13.43%
108.05%7.47%
88.51%-19.49%
46.68%-38.06%
96.92%-15.12%
20.99%-92.81%
87.60%-169.59%
97.52%-71.38%
79.85%-490.05%
---117.47%
---1367.84%
---2880.26%
---2432.25%
---33026.07%
----
----
----
----
Gross Margin
0.85%91.58%
4.77%90.72%
0.72%90.97%
4.04%91.25%
2.29%90.81%
-7.32%86.59%
8.31%90.32%
-9.49%87.70%
4.38%88.77%
30.05%93.43%
-0.27%83.39%
--96.90%
--85.05%
--71.84%
--83.62%
--62.90%
----
----
----
----
Debt to assets ratio
-27.29%22.29%
-23.94%23.79%
-18.10%25.17%
-37.48%29.25%
-33.10%30.66%
-26.20%31.27%
-48.02%30.73%
-31.74%46.78%
-26.44%45.82%
-19.09%42.38%
34.29%59.12%
--68.54%
--62.29%
--52.38%
--44.02%
--38.66%
----
----
----
----
Income Statement
Revenue
59.33%129.86M
60.07%105.40M
81.48%129.50M
121.69%99.22M
164.13%81.50M
32.84%65.85M
427.58%71.36M
17.44%44.76M
494.57%30.86M
1682.42%49.57M
356.81%13.53M
5156.41%38.11M
--5.19M
--2.78M
--2.96M
--725.00K
----
----
----
----
Operating profit
212.44%16.43M
62.95%-9.09M
340.92%18.39M
121.82%8.53M
70.82%-14.61M
22.43%-24.53M
87.52%-7.63M
-5.86%-39.07M
24.99%-50.08M
58.54%-31.62M
10.60%-61.17M
64.77%-36.90M
-1.42%-66.76M
-21.77%-76.27M
4.01%-68.42M
-83.52%-104.75M
-56.43%-65.83M
-73.56%-62.63M
-109.27%-71.29M
-49.02%-57.08M
Net Profit
194.48%15.01M
54.93%-11.29M
261.24%17.39M
117.84%7.41M
69.64%-15.89M
29.17%-25.06M
83.72%-10.79M
7.21%-41.54M
26.28%-52.33M
55.83%-35.38M
7.96%-66.28M
58.44%-44.77M
-5.32%-70.99M
-24.53%-80.10M
-0.97%-72.02M
-89.03%-107.71M
-60.46%-67.41M
-78.47%-64.32M
-109.48%-71.33M
-49.15%-56.98M
Balance Sheet
Current assets
40.54%467.67M
35.34%438.06M
22.46%411.23M
-17.58%349.22M
-23.43%332.78M
-30.85%323.67M
1.63%335.82M
50.50%423.72M
40.70%434.59M
27.30%468.06M
-24.46%330.43M
-43.32%281.55M
4.55%308.87M
2.44%367.68M
8.60%437.41M
30.11%496.72M
-30.90%295.43M
-22.97%358.92M
37.55%402.77M
96.67%381.77M
Total current liabilities
54.27%160.34M
79.09%163.20M
60.27%129.84M
-42.14%99.77M
102.40%103.94M
92.63%91.13M
73.59%81.01M
311.63%172.43M
40.08%51.35M
27.78%47.31M
23.44%46.67M
12.90%41.89M
33.39%36.66M
12.32%37.02M
13.45%37.81M
94.68%37.10M
105.90%27.48M
115.25%32.96M
47.45%33.33M
-9.91%19.06M
Total assets
38.62%488.54M
33.68%460.00M
24.10%432.97M
-15.18%370.98M
-20.76%352.43M
-28.09%344.11M
2.20%348.89M
49.29%437.35M
38.69%444.76M
26.11%478.54M
-24.02%341.37M
-42.43%292.96M
6.73%320.69M
4.22%379.46M
10.08%449.27M
31.50%508.91M
-30.59%300.46M
-22.76%364.11M
36.84%408.15M
95.45%387.01M
Total liabilities
25.53%267.96M
34.21%270.36M
27.25%243.49M
-24.16%212.90M
-17.37%213.46M
-20.56%201.45M
-24.28%191.35M
14.00%280.71M
7.56%258.33M
5.79%253.60M
5.43%252.70M
3.40%246.24M
128.57%240.18M
117.27%239.73M
116.97%239.69M
891.71%238.14M
470.97%105.08M
440.28%110.34M
299.58%110.47M
-3.72%24.01M
Total equity
58.72%220.58M
32.94%189.65M
20.27%189.48M
0.91%158.07M
-25.45%138.97M
-36.58%142.66M
77.68%157.54M
235.30%156.64M
131.56%186.43M
60.98%224.94M
-57.69%88.67M
-82.75%46.72M
-58.79%80.51M
-44.94%139.73M
-29.59%209.58M
-25.41%270.77M
-52.86%195.38M
-43.73%253.77M
10.00%297.68M
109.74%363.00M
Cash Flow Statement
Net operating income
3800.93%12.64M
107.37%2.24M
3600.67%26.18M
94.94%-1.75M
100.72%324.00K
3.87%-30.38M
98.67%-748.00K
21.13%-34.69M
32.14%-45.12M
60.67%-31.60M
20.86%-56.24M
35.03%-43.98M
-7.27%-66.48M
-41.02%-80.34M
-37.43%-71.06M
-65.58%-67.69M
-72.98%-61.98M
-23.31%-56.98M
-58.76%-51.71M
-21.35%-40.88M
Net investment
-187.38%-15.22M
-196.44%-11.33M
-198.00%-34.18M
-129.78%-25.25M
128.04%17.42M
140.95%11.75M
156.08%34.88M
86.12%84.78M
-169.72%-62.14M
-126.63%-28.70M
-247.36%-62.19M
123.09%45.55M
69.54%89.12M
604.39%107.75M
79.59%42.20M
-5783.15%-197.26M
131.87%52.56M
-75.33%15.30M
130.96%23.50M
103.78%3.47M
Net financing
44.20%1.99M
170.13%1.07M
103.82%3.72M
274.62%1.48M
-5.15%1.38M
-99.76%395.00K
-198.11%-97.41M
-54.56%394.00K
36.36%1.46M
161664.00%161.76M
10221.10%99.29M
-99.70%867.00K
-5.66%1.07M
-99.32%100.00K
-98.68%962.00K
452263.49%284.99M
-4.80%1.13M
-92.92%14.72M
-43.67%72.88M
114.42%63.00K

FAQs

What is the total revenue of Arcutis Biotherapeutics Inc?

According to Arcutis Biotherapeutics Inc's FY2025 earnings report, its total revenue reached 376.07M, with a year-on-year change of 196.54M.

What are the current assets of Arcutis Biotherapeutics Inc?

According to Arcutis Biotherapeutics Inc's FY2025 earnings report, its current assets were 411.23M, with a year-on-year change of 22.46.

What are the total assets of Arcutis Biotherapeutics Inc?

According to Arcutis Biotherapeutics Inc's FY2025 earnings report, its total assets of Arcutis Biotherapeutics Inc were 432.97M, with a year-on-year change of 24.10.

What are the total liabilities of Arcutis Biotherapeutics Inc?

According to Arcutis Biotherapeutics Inc's FY2025 earnings report, its total liabilities of Arcutis Biotherapeutics Inc were 243.49M, with a year-on-year change of 27.25.

What is the total equity of Arcutis Biotherapeutics Inc?

According to Arcutis Biotherapeutics Inc's FY2025 earnings report, its total equity of Arcutis Biotherapeutics Inc was 189.48M, with a year-on-year change of 20.27.

What is the net operating income of Arcutis Biotherapeutics Inc?

According to Arcutis Biotherapeutics Inc's FY2025 earnings report, its net operating income of Arcutis Biotherapeutics Inc was -12.23M, with a year-on-year change of 90.48.

What is the net investment of Arcutis Biotherapeutics Inc?

According to Arcutis Biotherapeutics Inc's FY2025 earnings report, its net investment of Arcutis Biotherapeutics Inc was -30.25M, with a year-on-year change of -204.97.

What is the net financing of Arcutis Biotherapeutics Inc?

According to Arcutis Biotherapeutics Inc's FY2025 earnings report, its net financing of Arcutis Biotherapeutics Inc was 6.97M, with a year-on-year change of -89.47.

What is the Earnings Per Share (EPS) of Arcutis Biotherapeutics Inc?

According to Arcutis Biotherapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.13, with a year-on-year change of 89.04.

What is the net income of Arcutis Biotherapeutics Inc?

According to Arcutis Biotherapeutics Inc's FY2025 earnings report, its net income was -16.14M, with a year-on-year change of 88.47.

What is the net margin of Arcutis Biotherapeutics Inc?

According to Arcutis Biotherapeutics Inc's FY2025 earnings report, its net profit margin was -4.29, with a year-on-year change of 93.98.

What is the gross margin of Arcutis Biotherapeutics Inc?

According to Arcutis Biotherapeutics Inc's FY2025 earnings report, its gross margin was 90.24, with a year-on-year change of -0.03.

What is the debt-to-asset ratio of Arcutis Biotherapeutics Inc?

According to Arcutis Biotherapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 25.17, with a year-on-year change of -18.10.

What is the Return on Equity (ROE) of Arcutis Biotherapeutics Inc?

According to Arcutis Biotherapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -9.30, with a year-on-year change of 91.82.

What is the Return on Assets (ROA) of Arcutis Biotherapeutics Inc?

According to Arcutis Biotherapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -4.13, with a year-on-year change of 89.82.

What is the operating profit of Arcutis Biotherapeutics Inc?

According to Arcutis Biotherapeutics Inc's FY2025 earnings report, its operating profit was -12.23M, with a year-on-year change of 90.48.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy